Feedback / Questions
Bizengri (zenocutuzumab-zbco) - Merus, Partner Therap
https://www.prnewswire.com/news-releases/zenocutuzumabzbco-receives-fda-orphan-drug-designation-for-treatment-of-cholangiocarcinoma-302680533.html
Feb 5, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next